Brivaracetam
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0121-1075 -
Package NDC
0121-1075-02 -
Application number
ANDA218249 -
SPL ID
c0702161-ae73-4aac-b6fd-fb3fa7c841b8 -
SPL set ID
5bc0f4c0-8b31-4622-849f-d902be93788b -
UNII
U863JGG2IA -
RxCUI
1739749
What the source publishes
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Active ingredients
- Brivaracetam Injection
- Form
- INJECTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Brivaracetam",
"splId": "c0702161-ae73-4aac-b6fd-fb3fa7c841b8",
"labels": [
{
"setId": "5bc0f4c0-8b31-4622-849f-d902be93788b",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bc0f4c0-8b31-4622-849f-d902be93788b",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5bc0f4c0-8b31-4622-849f-d902be93788b"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "PAI Holdings, LLC dba PAI Pharma",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 VIAL, GLASS in 1 CARTON (0121-1075-02) / 5 mL in 1 VIAL, GLASS (0121-1075-55)",
"package_ndc": "0121-1075-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260223"
}
],
"productId": "0121-1075_c0702161-ae73-4aac-b6fd-fb3fa7c841b8",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "0121-1075",
"deaSchedule": "CV",
"genericName": "Brivaracetam Injection",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BRIVARACETAM",
"strength": "50 mg/5mL"
}
],
"applicationNumber": "ANDA218249",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260223",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000192345"
],
"upc": [
"0301211075550"
],
"unii": [
"U863JGG2IA"
],
"rxcui": [
"1739749"
],
"spl_set_id": [
"5bc0f4c0-8b31-4622-849f-d902be93788b"
],
"pharm_class_moa": [
"Epoxide Hydrolase Inhibitors [MoA]"
],
"manufacturer_name": [
"PAI Holdings, LLC dba PAI Pharma"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0121-1075_c0702161-ae73-4aac-b6fd-fb3fa7c841b8"